To select for cancer-marker-activated enzymes, we coexpressed the library of yCD-CH1 fusions along with the C-terminal activation domain (CTAD) of HIF-1α, which has been shown to interact strongly with the CH1 domain in E. coli[30],[31]. The gene discussed is HIF1A; the disease is cancer.